Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
ABIVAX Société Anonyme ENXTPA:ABVX |
8,03 B | 10,49% | 1/5 | 145,34% | -229,02% | 25,96% | UP |
|
Virbac ENXTPA:VIRP |
2,94 B | 12,18% | 6/6 | 8,63% | 4,93% | 18,23% | UP |
|
Nanobiotix ENXTPA:NANO |
1,33 B | -16,62% | 4/6 | -100,00% | -118,35% | 16,79% | UP |
|
DBV Technologies ENXTPA:DBV |
1,01 B | -30,81% | 3/5 | 32,19% | -271,90% | 37,36% | UP |
|
Inventiva ENXTPA:IVA |
0,90 B | -15,91% | 0/6 | 24,77% | -130,68% | 90,68% | UP |
|
Valneva ENXTPA:VLA |
0,47 B | -2,41% | 2/6 | -5,13% | -33,51% | 106,64% | DOWN |
|
Genfit ENXTPA:GNFT |
0,43 B | 14,40% | 5/6 | 95,18% | -105,15% | 66,28% | UP |
|
Cellectis ENXTPA:ALCLS |
0,23 B | -17,05% | 4/6 | 14,58% | -40,07% | 109,00% | DOWN |
|
Eurobio Scientific Société anonyme ENXTPA:ALERS |
0,23 B | 19,42% | 6/6 | 26,74% | -46,14% | 33,33% | DOWN |
|
Transgene ENXTPA:TNG |
0,20 B | -17,19% | 1/6 | -13,38% | -89,29% | 48,65% | DOWN |
|
ABIONYX Pharma ENXTPA:ABNX |
0,13 B | 0,00% | 2/5 | -9,53% | -356,00% | 183,78% | UP |
|
MaaT Pharma ENXTPA:MAAT |
0,11 B | 0,00% | 0/0 | 100,00% | -23,00% | 197,20% | UP |
|
Innate Pharma ENXTPA:IPH |
0,11 B | -27,49% | 0/6 | -26,71% | -10,53% | 361,21% | DOWN |
|
Oncodesign Société Anonyme ENXTPA:ALONC |
0,10 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Adocia ENXTPA:ADOC |
0,09 B | -7,22% | 4/6 | 217,04% | 9,63% | 201,72% | DOWN |
|
OSE Immunotherapeutics ENXTPA:OSE |
0,07 B | 17,32% | 5/6 | -42,63% | 50,31% | 295,14% | DOWN |
|
Valerio Therapeutics Société anonyme ENXTPA:ALVIO |
0,06 B | -17,81% | 3/6 | 0,00% | 10,32% | -100,00% | UP |
|
GenSight Biologics ENXTPA:SIGHT |
0,02 B | -33,93% | 2/5 | 97,15% | 84,35% | 244,44% | DOWN |
|
Aelis Farma ENXTPA:AELIS |
0,02 B | -21,47% | 0/4 | 122,43% | 48,74% | -100,00% | DOWN |
|
Poxel ENXTPA:POXEL |
0,02 B | -44,44% | 2/6 | 0,00% | -128,32% | -100,00% | DOWN |
